This afternoon we watched Inspire Medical Systems drop -5.1% to a price of $194.0 per share. The Mid-Cap Medical Instruments & Supplies company is now trading -23.28% below its average target price of $252.87. Analysts have set target prices ranging from $187.0 to $280.0 per share for Inspire Medical Systems, and have given the stock an average rating of buy.
Inspire Medical Systems has an average level of shares sold short, at 6.7% of its total share float. The stock's short ratio (also called days to cover) is 3.17. Since 1.72% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests.
Institutional investors own 106.7% of Inspire Medical Systems's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Inspire Medical Systems
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-12-31 | FMR, LLC | 11% | 3,257,544 | $631,963,536 |
| 2023-12-31 | Vanguard Group Inc | 10% | 2,931,469 | $568,704,986 |
| 2023-12-31 | Blackrock Inc. | 6% | 1,800,207 | $349,240,158 |
| 2023-12-31 | Wellington Management Group, LLP | 5% | 1,430,266 | $277,471,604 |
| 2023-12-31 | Baillie Gifford and Company | 4% | 1,229,879 | $238,596,526 |
| 2023-12-31 | Wasatch Advisors LP | 4% | 1,097,345 | $212,884,930 |
| 2023-12-31 | Farallon Capital Management LLC | 3% | 855,096 | $165,888,624 |
| 2023-12-31 | William Blair Investment Management, LLC | 3% | 806,947 | $156,547,718 |
| 2023-12-31 | Frontier Capital Management Company LLC | 3% | 742,046 | $143,956,924 |
| 2023-12-31 | Champlain Investment Partners, LLC | 2% | 648,595 | $125,827,430 |
